Primun non nocere

Primun non nocere

Contenido principal del artículo

Jairo Echeverry Raad

Palabras clave:

Descargas

Los datos de descargas todavía no están disponibles.

Detalles del artículo

Biografía del autor/a (VER)

Jairo Echeverry Raad, Fundación Universitaria Juan N Corpas

Profesor titular. Departamento de Pediatría, Facultad de Medicina. Universidad Nacional de Colombia

Referencias (VER)

(1) Del Río L, Soto SC, Camargo M, Sánchez R, Mancilla CL, Patarroyo ME, et al. The Prevalence of High-Risk HPV Types and Factors Determining Infection in Female Colombian Adolescents. PLoS ONE. 2016; 11(11): e0166502. doi:10.1371/journal.pone.0166502 DOI: https://doi.org/10.1371/journal.pone.0166502

(2) Pimenta J, Borges I. Efficacy of the Vaccines against Human Papillomavirus in Women Older than 24 Years in the Cervix Cancer Prevention. Acta Med Port. 2016; 29(6): 401-408. doi: 10.20344/amp.7095. Epub 2016 Jun 30.

(3) Francis T. Evaluation of the 1954 Poliomyelitis Vaccine Field Trialfurther Studies of Results Determining the Effectiveness of Poliomyelitis Vaccine (Salk) in Preventing Paralytic Poliomyelitis. JAMA. 1955; 158(14):1266-1270. doi:10.1001/jama.1955.02960140028004 DOI: https://doi.org/10.1001/jama.1955.02960140028004

(4) Centers for Disease Control and Prevention (CDC). Withdrawal of Rotavirus Vaccine Recommendation. MMWR Morb Mortal Wkly Rep 1999; 48:1007.